Core Viewpoint - The Dow class action lawsuit alleges that Dow Inc. and its executives made misleading statements regarding the company's financial health and ability to manage macroeconomic challenges, leading to significant investor losses during the specified class period [3][4][5]. Summary by Sections Class Action Details - The class action lawsuit, titled Sarti v. Dow Inc., is open for investors who purchased Dow securities between January 30, 2025, and July 23, 2025, to seek appointment as lead plaintiff by October 28, 2025 [1][6]. Allegations Against Dow - The lawsuit claims that Dow overstated its ability to handle macroeconomic and tariff-related challenges, and understated the negative impacts of competitive pressures, softening global sales, and product oversupply on its business [3][4]. - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, which was followed by a stock price drop of over 3% [4]. - Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of approximately $0.17 to $0.18, with net sales of $10.1 billion reflecting a 7.3% year-over-year decline [5]. Financial Impact - Following the disappointing Q2 results, Dow announced a dividend cut from $0.70 to $0.35 per share, citing the need for financial flexibility in a challenging macroeconomic environment, which led to a stock price decline of over 17% [5]. Legal Process - The Private Securities Litigation Reform Act of 1995 allows any investor who purchased Dow securities during the class period to seek lead plaintiff status, which enables them to act on behalf of all class members [6]. About Robbins Geller - Robbins Geller Rudman & Dowd LLP is a leading law firm in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [7][8].

Core Viewpoint - Dow Inc. is expected to report significant losses in its upcoming fiscal third-quarter earnings, reflecting ongoing challenges in the materials science sector and underperformance compared to market indices [1][2][4]. Financial Performance - Analysts predict a loss of $0.27 per share for Dow in Q3 2025, a decline of 157.5% from a profit of $0.47 per share in the same quarter last year [2]. - For the full fiscal year, a loss of $0.89 per share is anticipated, down 152.1% from an EPS of $1.71 in fiscal 2024, but a recovery to $0.20 EPS is expected in fiscal 2026, representing a year-over-year increase of 122.5% [3]. Stock Performance - Dow's stock has decreased by 57.7% over the past 52 weeks, significantly underperforming the S&P 500 Index, which gained 17.2% during the same period [4]. - The stock also underperformed compared to the Materials Select Sector SPDR Fund, which saw a loss of 5.7% [4]. Challenges and Market Conditions - The company's underperformance is attributed to lower prices, restructuring charges, and decreased sales across all segments, particularly in functional polymers, polyurethanes, and coatings [5]. - Margin compression has further impacted earnings, and the company is seeking regulatory intervention to address issues related to oversupply and unfair pricing practices [5]. Analyst Sentiment - The consensus opinion among analysts is cautious, with a "Hold" rating overall; out of 20 analysts, 2 recommend a "Strong Buy," 16 suggest a "Hold," and 2 advise a "Strong Sell" [7]. - The average analyst price target for Dow is $27.67, indicating a potential upside of 18.1% from current levels [7].

Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, focusing on misleading statements regarding the company's financial health and performance during a specified class period [1][4]. Company Allegations - The lawsuit claims that Dow and its executives made false statements about the company's ability to handle macroeconomic challenges and maintain financial flexibility for dividends, which were overstated [4]. - It is alleged that Dow failed to disclose the true impact of competitive pressures, declining global sales, and product oversupply on its business [4]. Financial Performance - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00 due to ongoing weaknesses in key markets, leading to a stock price drop of over 3% [5]. - Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of approximately $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline, missing estimates by $130 million [6]. - Following the disappointing earnings report, Dow's stock price fell by more than 17%, and the company announced a dividend cut from $0.70 to $0.35 per share to maintain financial flexibility amid challenging conditions [6]. Legal Process - Investors who purchased Dow securities during the class period can seek to be appointed as lead plaintiff in the lawsuit, representing the interests of the class [7]. - The lead plaintiff can choose a law firm to litigate the case, and participation as lead plaintiff does not affect the ability to share in any potential recovery [7]. About the Law Firm - Robbins Geller Rudman & Dowd LLP is a leading law firm specializing in securities fraud and shareholder litigation, having recovered over $2.5 billion for investors in 2024 alone [8].

Core Viewpoint - The article discusses a class action lawsuit against Dow Inc. for alleged violations of the Securities Exchange Act of 1934, with claims of misleading statements regarding the company's financial health and ability to manage macroeconomic challenges [1][3]. Company Allegations - The lawsuit alleges that Dow overstated its ability to handle macroeconomic and tariff-related challenges, and understated the negative impacts of competitive pressures, softening global sales, and product oversupply on its business [3]. - On June 23, 2025, BMO Capital downgraded Dow's stock from "Market Perform" to "Underperform," reducing the price target from $29.00 to $22.00, citing ongoing weakness in key markets and pressure on dividends [4]. - Dow reported a non-GAAP loss per share of $0.42 for Q2 2025, significantly worse than the expected loss of $0.17 to $0.18, with net sales of $10.1 billion, a 7.3% year-over-year decline, missing estimates by $130 million [5]. Financial Impact - Following the downgrade by BMO Capital, Dow's stock price fell by over 3% [4]. - After the Q2 2025 earnings report, Dow's stock price dropped by more than 17%, and the company announced a dividend cut from $0.70 to $0.35 per share to maintain financial flexibility in a challenging environment [5].